Press releases
Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
16 Apr 24
Press Releases
Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases
13 Mar 24
Health Care, Press Releases, General
Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases
13 Mar 24
Press Releases